Investor Relations (IR) Questions: Enzo Biochem $ENZ
Click here to return to the biotech IRQ Index
Answers received: June 2013
1) When is the last time ENZ raised cash through an offering (diluted)? 2006
2) How much cash (not cash equivalents) does ENZ have? As stated in recent conference call, cash approximated $10 million
3) What and approximately when is the next known catalyst?
There several possibilities, but dates unknown:
a-Awaiting sign-off by federal judge in New Haven re jury decision, and interest cost requests
b-Court trial scheduled for November, and in light of New Haven favorable verdict could result in settlement before trial
b-Several diagnostic tests and the AmpiProbe platform awaiting NY State Department of Health approval
c-Pending results of clinical trial for Optiquel
d-Pursuing partnering relations in different areas of business
4) What is ENZ's quarterly cash burn? We do not typically release tis figure, since the chief variable is attorney fees, which are expensed as incurred and been sizable because of lititgation calendar in New Haven and New York .
5) Does ENZ have an existing line of credit and if so how much can they draw against it? We announced last month an $8.0 Million Senior Secured Revolving Credit Facility
1) When is the last time ENZ raised cash through an offering (diluted)? 2006
2) How much cash (not cash equivalents) does ENZ have? As stated in recent conference call, cash approximated $10 million
3) What and approximately when is the next known catalyst?
There several possibilities, but dates unknown:
a-Awaiting sign-off by federal judge in New Haven re jury decision, and interest cost requests
b-Court trial scheduled for November, and in light of New Haven favorable verdict could result in settlement before trial
b-Several diagnostic tests and the AmpiProbe platform awaiting NY State Department of Health approval
c-Pending results of clinical trial for Optiquel
d-Pursuing partnering relations in different areas of business
4) What is ENZ's quarterly cash burn? We do not typically release tis figure, since the chief variable is attorney fees, which are expensed as incurred and been sizable because of lititgation calendar in New Haven and New York .
5) Does ENZ have an existing line of credit and if so how much can they draw against it? We announced last month an $8.0 Million Senior Secured Revolving Credit Facility